CELU.NASDAQCelularity INC

Form 4: Celularity Inc. Executive Stephen Brigido Reports Stock Transactions

Sentiment:

SEC Form 4


Stephen Brigido, Pres. of Functional Regeneration at Celularity Inc., reports the vesting of restricted stock units and subsequent tax withholding.

Summary

  • On February 17, 2025, Stephen Brigido, Pres. of Functional Regeneration at Celularity Inc., reported transactions involving Class A Common Stock.
  • 10,000 restricted stock units (RSUs) vested and were converted into 10,000 shares of Class A Common Stock.
  • 3,272 shares were disposed of to cover tax withholding obligations at a price of $2.14 per share.
  • Following these transactions, Brigido directly owns 8,369 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: This is a routine filing related to executive compensation and stock transactions, with no inherently positive or negative implications for the company's overall outlook.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.

Key Dates

DateDescription
02/17/2023Reporting person was granted 10,000 RSUs
02/22/2023Previous Form 4 filed with the SEC
02/17/2025RSUs vested and converted into Class A Common Stock; tax withholding occurred
02/18/2025Date of signature on the Form 4

Keywords

Form 4, Celularity Inc, Stephen Brigido, CELU, Restricted Stock Units, RSUs, Vesting, Class A Common Stock, Tax Withholding, Officer, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.